Flopped COVID Drug Trial Spurs Corporate Waste Suit
Biopharmaceutical company FSD Biosciences Inc.'s top brass had "fatal conflicts of interest" leading them to abruptly abandon clinical trials for an anti-inflammatory COVID-19 treatment drug, an investor alleged in a derivative...To view the full article, register now.
Already a subscriber? Click here to view full article